amifostine anhydrous has been researched along with Opportunistic Infections in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avilés, A | 1 |
| Díaz-Maqueo, JC | 1 |
| Talavera, A | 1 |
| García, EL | 1 |
| Guzmán, R | 1 |
| Nambo, MJ | 1 |
1 trial available for amifostine anhydrous and Opportunistic Infections
| Article | Year |
|---|---|
Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma.
Topics: Adult; Agranulocytosis; Amifostine; Antineoplastic Agents, Alkylating; Bone Marrow; Cyclophosphamide | 1997 |